Artisan Partners Limited Partnership Ascendis Pharma A/S Put Options Transaction History
Artisan Partners Limited Partnership
- $58.2 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ASND
# of Institutions
272Shares Held
61.8MCall Options Held
151KPut Options Held
226K-
Ra Capital Management, L.P. Boston, MA10.3MShares$1.7 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$907 Million4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$864 Million13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$743 Million0.4% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.05MShares$506 Million0.31% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.24B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...